MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 134 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.56 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $114,641 | -33.3% | 785 | +5.5% | 0.01% | -25.0% |
Q2 2023 | $171,864 | +4.2% | 744 | +9.3% | 0.01% | 0.0% |
Q1 2023 | $164,979 | -25.4% | 681 | -10.6% | 0.01% | -20.0% |
Q4 2022 | $221,171 | +346.6% | 762 | 0.0% | 0.01% | +400.0% |
Q3 2022 | $49,522 | -9.2% | 762 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $54,544 | -27.0% | 762 | 0.0% | 0.00% | -33.3% |
Q1 2022 | $74,767 | -72.7% | 762 | -76.4% | 0.00% | -25.0% |
Q4 2021 | $273,710 | +6.2% | 3,230 | 0.0% | 0.00% | 0.0% |
Q3 2021 | $257,722 | -18.1% | 3,230 | 0.0% | 0.00% | 0.0% |
Q2 2021 | $314,634 | +5.9% | 3,230 | +27.2% | 0.00% | 0.0% |
Q1 2021 | $297,104 | +0.2% | 2,540 | -4.8% | 0.00% | 0.0% |
Q4 2020 | $296,602 | -6.4% | 2,668 | 0.0% | 0.00% | -33.3% |
Q3 2020 | $316,772 | +4.8% | 2,668 | 0.0% | 0.01% | +20.0% |
Q2 2020 | $302,151 | +69.6% | 2,668 | 0.0% | 0.01% | +25.0% |
Q1 2020 | $178,116 | -26.7% | 2,668 | 0.0% | 0.00% | 0.0% |
Q4 2019 | $243,081 | +5.7% | 2,668 | 0.0% | 0.00% | 0.0% |
Q3 2019 | $230,035 | -6.6% | 2,668 | +13.6% | 0.00% | 0.0% |
Q2 2019 | $246,199 | -13.1% | 2,349 | +3.8% | 0.00% | -20.0% |
Q1 2019 | $283,338 | +11.1% | 2,262 | 0.0% | 0.01% | 0.0% |
Q4 2018 | $254,973 | -47.4% | 2,262 | 0.0% | 0.01% | -44.4% |
Q3 2018 | $484,362 | -99.9% | 2,262 | +17.3% | 0.01% | 0.0% |
Q2 2018 | $539,522,000 | +218.8% | 1,929 | +33.1% | 0.01% | +350.0% |
Q1 2018 | $169,229,000 | +127139.8% | 1,449 | 0.0% | 0.00% | 0.0% |
Q4 2017 | $133,000 | – | 1,449 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tao Capital Management LP | 77,657 | $5,047,000 | 3.31% |
L1 Capital Pty Ltd | 161,163 | $10,474,000 | 2.05% |
Avoro Capital Advisors LLC | 1,535,000 | $99,760,000 | 1.84% |
Affinity Asset Advisors, LLC | 100,000 | $6,499,000 | 1.81% |
GREAT POINT PARTNERS LLC | 95,500 | $6,207,000 | 1.50% |
ARMISTICE CAPITAL, LLC | 1,236,000 | $80,328,000 | 1.39% |
Affinity Asset Advisors, LLC | 75,000 | $4,874,000 | 1.36% |
MPM BioImpact LLC | 44,747 | $2,908,000 | 0.69% |
Baker Brothers Advisors | 1,499,213 | $97,434,000 | 0.64% |
Perceptive Advisors | 331,023 | $21,513,000 | 0.62% |